Ajanta Pharma reports 25% rise in Q3 consolidated net profit

24 Jan 2017 Evaluate

Ajanta Pharma has reported results for third quarter ended December 31, 2016. 

The company has reported 64.58% rise in its net profit at Rs 170.98 crore for the quarter under review as compared to Rs 103.89 crore for the same quarter in the previous year. Total income of the company increased by 30.52% at Rs 559.68 crore for the quarter under review as compared to Rs 428.81 crore for the corresponding quarter previous year. 

On the consolidated basis, the company has reported 25.15% rise in its net profit at Rs 142.60 crore for the quarter ended December 31, 2016, as compared to Rs 113.94 crore for the same quarter in the previous year. Total income of the company increased by 15.31% to Rs 552.30 crore for quarter under review from Rs 478.96 crore for the quarter ended December 31, 2015.

Ajanta Pharma Share Price

2917.50 147.25 (5.32%)
01-Jan-2026 14:07 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1719.25
Dr. Reddys Lab 1250.80
Cipla 1499.60
Zydus Lifesciences 913.40
Lupin 2101.75
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×